Systemic Drug Reactions Due to Rifapentine-Based Short-Course Regimens for Latent Tuberculosis Infection: Training and Testing for Population Pharmacokinetics and Prediction Model Using Clinical Risk Factors and Transcriptomic Signature

Project title

含有rifapentine之短程潛伏結核感染治療處方所發生之全身性藥物反應：建構與確認群體藥物動力學以及臨床和基因表現整合的預測模式

Internal ID

NSTC111-2314-B002-151-MY3

Principal Investigator

Start Date

August 1, 2023

End Date

July 31, 2024

Organizations

Internal Medicine

Partner Organizations

National Science and Technology Council